{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:58:56Z","timestamp":1791406736520,"version":"4.3.3"},"reference-count":217,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2016.00115","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T18:09:00Z","timestamp":1466705340000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Anti-Cancer Stem-like Cell Compounds in Clinical Development \u2013 An Overview and Critical Appraisal"],"prefix":"10.3389","volume":"6","author":[{"given":"Fabrizio","family":"Marcucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Rumio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lefoulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e43628","DOI":"10.1371\/journal.pone.0043628","article-title":"Ionizing radiation induces stemness in cancer cells","volume":"7","author":"Ghisolfi","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.4161\/cc.21021","article-title":"Induction of cancer cell stemness by chemotherapy","volume":"11","author":"Hu","year":"2012","journal-title":"Cell Cycle"},{"key":"B4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells \u2013 what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1158\/0008-5472.CAN-14-0826","article-title":"Targeting the c-Met\/FZD8 signaling axis eliminates patient-derived cancer stem-like cells in head and neck squamous carcinomas","volume":"74","author":"Sun","year":"2014","journal-title":"Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Bapat","year":"2005","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","article-title":"Prospective identification of tumorigenic prostate cancer stem cells","volume":"65","author":"Collins","year":"2005","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"key":"B11","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature09781","article-title":"Cells of origin in cancer","volume":"469","author":"Visvader","year":"2011","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12094-006-0035-7","article-title":"Somatic stem cells and the origin of cancer","volume":"8","author":"Martinez-Climent","year":"2006","journal-title":"Clin Transl Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.18632\/oncotarget.6580","article-title":"Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma","volume":"7","author":"Vaz","year":"2016","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1158\/0008-5472.CAN-14-1022","article-title":"Epigenetic targeting of ovarian cancer stem cells","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/ijc.28572","article-title":"Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads","volume":"135","author":"Marcucci","year":"2014","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1172\/JCI57099","article-title":"Breast cancer stem cells, cytokine networks, and the tumor microenvironment","volume":"121","author":"Korkaya","year":"2011","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.4161\/cc.3.9.1130","article-title":"Cytokine overexpression and constitutive NF-\u03baB in cancer","volume":"3","author":"Lu","year":"2004","journal-title":"Cell Cycle"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1038\/ncomms4729","article-title":"Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3\/B4","volume":"5","author":"Catanzaro","year":"2014","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions","volume":"8","author":"Visvader","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/S1470-2045(11)70257-1","article-title":"The developing cancer stem-cell model: clinical challenges and opportunities","volume":"13","author":"Vermeulen","year":"2012","journal-title":"Lancet Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1004025","DOI":"10.1371\/journal.pcbi.1004025","article-title":"Evolution and phenotypic selection of cancer stem cells","volume":"11","author":"Poleszczuk","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","article-title":"EMT and dissemination precede pancreatic tumor formation","volume":"148","author":"Rhim","year":"2012","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial\u2212mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: when epithelial cells decide to become mesenchymal-like cells","volume":"119","author":"Kalluri","year":"2009","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1158\/1078-0432.CCR-14-2808","article-title":"Targeting Notch signaling with a Notch2\/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency","volume":"21","author":"Yen","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.13","article-title":"Epithelial-mesenchymal transition: a new target in anticancer drug discovery","author":"Marcucci","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1242\/jcs.120907","article-title":"Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis","volume":"126","author":"Frisch","year":"2013","journal-title":"J Cell Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","article-title":"Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1","volume":"22","author":"Oca\u00f1a","year":"2012","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.15252\/emmm.201404208","article-title":"Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients","volume":"6","author":"Tan","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/1471-2407-12-556","article-title":"Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt","volume":"12","author":"Kuo","year":"2012","journal-title":"BMC Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.celrep.2014.08.034","article-title":"Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance","volume":"8","author":"Wiener","year":"2014","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/biores.2014.0035","article-title":"Autophagy in cancer stem cells: a potential link between chemoresistance, recurrence, and metastasis","volume":"4","author":"Ojha","year":"2015","journal-title":"Biores Open Access"},{"key":"B38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-015-0449-3","article-title":"Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine","volume":"14","author":"Yang","year":"2015","journal-title":"Mol Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/1471-2407-14-651","article-title":"Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer","volume":"14","author":"Papadaki","year":"2014","journal-title":"BMC Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1149","DOI":"10.1038\/cddis.2014.115","article-title":"Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)","volume":"5","author":"Diessner","year":"2014","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1158\/1078-0432.CCR-14-1399","article-title":"Inhibition of CD47 effectively targets pancreatic cancer stem cells via dual mechanisms","volume":"21","author":"Cioffi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1158\/0008-5472.CAN-13-1407","article-title":"Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III","volume":"74","author":"Emlet","year":"2014","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1158\/0008-5472.CAN-12-0254","article-title":"Clusterin mediates TGF-\u03b2-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cells","volume":"72","author":"Shiota","year":"2012","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/onc.2009.399","article-title":"Transcriptome profiling of a TGF-\u03b2-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies","volume":"29","author":"Lenferink","year":"2010","journal-title":"Oncogene"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.biocel.2012.09.012","article-title":"Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis","volume":"44","author":"Wang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"43375","DOI":"10.18632\/oncotarget.6234","article-title":"Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling","volume":"6","author":"Brandolini","year":"2015","journal-title":"Oncotarget"},{"key":"B48","doi-asserted-by":"publisher","first-page":"17266","DOI":"10.1073\/pnas.1419599111","article-title":"Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI39397","article-title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts","volume":"120","author":"Ginestier","year":"2010","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-12-3832","article-title":"Targeting ROR1 inhibits epithelial-mesenchymal transition and metastasis","volume":"73","author":"Cui","year":"2013","journal-title":"Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"37526","DOI":"10.18632\/oncotarget.6063","article-title":"Combinatorial TGF-\u03b2 attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1158\/0008-5472.CAN-13-3118","article-title":"Tumor-infiltrating myeloid cells activate Dll4\/Notch\/TGF-\u03b2 signaling to drive malignant progression","volume":"74","author":"Ohnuki","year":"2014","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-10-4554","article-title":"TGF\u03b2\/TNF\u03b1-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype","volume":"71","author":"Asiedu","year":"2011","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.cell.2011.04.029","article-title":"Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast","volume":"145","author":"Scheel","year":"2011","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","article-title":"Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"352","author":"Fan","year":"2014","journal-title":"Cancer Lett"},{"key":"B57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2014.05.006","article-title":"An novel inhibitor of TGF-\u03b2 type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition","volume":"351","author":"Park","year":"2014","journal-title":"Cancer Lett"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1158\/1078-0432.CCR-09-1634","article-title":"Anti-transforming growth factor \u03b2 receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells","volume":"16","author":"Zhong","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"16618","DOI":"10.1073\/pnas.1117610109","article-title":"TGF-\u03b2 blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma","volume":"109","author":"Liu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e90353","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1172\/JCI65416","article-title":"TGF-\u03b2 inhibition enhances chemotherapy action against triple-negative breast cancer","volume":"123","author":"Bhola","year":"2013","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF-\u03b2 signalling pathway","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B63","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1177\/0192623311416259","article-title":"Induction of heart valve lesions by small-molecule ALK5 inhibitors","volume":"39","author":"Anderton","year":"2011","journal-title":"Toxicol Pathol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bcp.12256","article-title":"Defining a therapeutic window for the novel TGF-\u03b2 inhibitor LY2157299 monohydrate based on a pharmacokinetic\/pharmacodynamic model","volume":"77","author":"Gueorguieva","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-14-0011","article-title":"CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance","volume":"20","author":"Yoon","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e27306","DOI":"10.1371\/journal.pone.0027306","article-title":"Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms","volume":"6","author":"Singh","year":"2011","journal-title":"PLoS One"},{"key":"B67","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1158\/1078-0432.CCR-14-1269","article-title":"Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma","volume":"20","author":"Kim","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-14-0776","article-title":"FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation","volume":"20","author":"Kim","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/1078-0432.CCR-12-3654","article-title":"Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors","volume":"19","author":"Jimeno","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.oraloncology.2015.11.014","article-title":"A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent\/metastatic head and neck squamous cell carcinoma","volume":"53","author":"Bowles","year":"2016","journal-title":"Oral Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature16466","article-title":"Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function","volume":"529","author":"Storm","year":"2016","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"11717","DOI":"10.1073\/pnas.1120068109","article-title":"Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors","volume":"109","author":"Gurney","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.08.005","article-title":"Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28","volume":"146","author":"Le","year":"2015","journal-title":"Pharmacol Ther"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/0008-5472.CAN-14-2041","article-title":"Wnt\/\u03b2-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells","volume":"75","author":"Jang","year":"2015","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"23720","DOI":"10.18632\/oncotarget.4690","article-title":"Critical role of Wnt\/\u03b2-catenin signaling in driving epithelial ovarian cancer platinum resistance","volume":"6","author":"Nagaraj","year":"2015","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/cas.12471","article-title":"Safely targeting cancer stem cells via selective catenin coactivator antagonism","volume":"105","author":"Lenz","year":"2014","journal-title":"Cancer Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1038\/onc.2015.54","article-title":"ECM1 regulates tumor metastasis and CSC-like property through stabilization of \u03b2-catenin","volume":"34","author":"Lee","year":"2015","journal-title":"Oncogene"},{"key":"B78","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/15680096113136660100","article-title":"Emerging role of mucins in epithelial to mesenchymal transition","volume":"13","author":"Ponnusamy","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"B79","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1158\/1078-0432.CCR-14-1373","article-title":"A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors","volume":"20","author":"Smith","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"302ra136","DOI":"10.1126\/scitranslmed.aac9459","article-title":"A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo","volume":"7","author":"Saunders","year":"2015","journal-title":"Sci Transl Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1158\/1078-0432.CCR-15-0695","article-title":"Anti-EFNA4 calicheamicin conjugates effectively target triple-negative breast and ovarian tumor-initiating cells to result in sustained tumor regressions","volume":"21","author":"Damelin","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1158\/1078-0432.CCR-12-0568","article-title":"Vismodegib","volume":"18","author":"Rudin","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1158\/1078-0432.CCR-14-0507","article-title":"Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells","volume":"21","author":"Justilien","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"32039","DOI":"10.18632\/oncotarget.5055","article-title":"PI3K\/AKT\/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth","volume":"6","author":"Sharma","year":"2015","journal-title":"Oncotarget"},{"key":"B86","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ccr.2012.07.016","article-title":"Suppression of acquired docetaxel resistance in prostate cancer through depletion of Notch and Hedgehog-dependent tumor-initiating cells","volume":"22","author":"Domingo-Domenech","year":"2012","journal-title":"Cancer Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1634\/stemcells.2007-0166","article-title":"Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma","volume":"25","author":"Bar","year":"2007","journal-title":"Stem Cells"},{"key":"B88","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccr.2014.01.008","article-title":"The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma","volume":"25","author":"Justilien","year":"2014","journal-title":"Cancer Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","article-title":"Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/emmm.200900039","article-title":"Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion","volume":"1","author":"Varnat","year":"2009","journal-title":"EMBO Mol Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation","volume":"14","author":"Dierks","year":"2008","journal-title":"Cancer Cell"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1073\/pnas.0611682104","article-title":"Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma","volume":"104","author":"Peacock","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B93","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature07275","article-title":"A paracrine requirement for hedgehog signalling in cancer","volume":"455","author":"Yauch","year":"2008","journal-title":"Nature"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/35023008","article-title":"Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine","volume":"406","author":"Taipale","year":"2000","journal-title":"Nature"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N Engl J Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMcibr1003522","article-title":"Acute myeloid leukemia and the Wnt pathway","volume":"362","author":"Eaves","year":"2010","journal-title":"N Engl J Med"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgt279","article-title":"Cancer stemness in Wnt-driven mammary tumorigenesis","volume":"35","author":"Monteiro","year":"2014","journal-title":"Carcinogenesis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","article-title":"Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers","volume":"142","author":"White","year":"2012","journal-title":"Gastroenterology"},{"key":"B102","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cellsig.2011.09.023","article-title":"Cellular signaling and biological functions of R-spondins","volume":"24","author":"Yoon","year":"2012","journal-title":"Cell Signal"},{"key":"B103","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrd4252","article-title":"Therapeutic modulation of Notch signalling \u2013 are we there yet?","volume":"13","author":"Andersson","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e25264","DOI":"10.1371\/journal.pone.0025264","article-title":"The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma","volume":"6","author":"Huynh","year":"2011","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2013.09.005","article-title":"Targeting Notch pathway in cancer: clinical development advances and challenges","volume":"141","author":"Takebe","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B106","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-14-3773","article-title":"Dll4 blockade in stromal cells mediates antitumor effects in preclinical models of ovarian cancer","volume":"75","author":"Kuhnert","year":"2015","journal-title":"Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1158\/1078-0432.CCR-14-2797","article-title":"A phase I first-in-human study of enoticumab (REGN421), a fully human Delta-like ligand 4 (Dll4) monoclonal antibody in patients with advanced solid tumors","volume":"21","author":"Chiorean","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1083\/jcb.200702009","article-title":"Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo","volume":"178","author":"Geffers","year":"2007","journal-title":"J Cell Biol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/hmg\/ddq529","article-title":"Notch inhibition by the ligand Delta-like 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis","volume":"20","author":"Chapman","year":"2011","journal-title":"Hum Mol Genet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrd4175","article-title":"Therapeutic targeting of EPH receptors and their ligands","volume":"13","author":"Boyd","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/hep.24454","article-title":"Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways","volume":"54","author":"Marquardt","year":"2011","journal-title":"Hepatology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3892\/ijo.2014.2357","article-title":"Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells","volume":"44","author":"Duong","year":"2014","journal-title":"Int J Oncol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"10194","DOI":"10.1038\/srep10194","article-title":"Inhibition of STAT3, FAK and Src mediated signaling reduces cancer stem cell load, tumorigenic potential and metastasis in breast cancer","volume":"5","author":"Thakur","year":"2015","journal-title":"Sci Rep"},{"key":"B115","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/stem.1843","article-title":"Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy","volume":"33","author":"Williams","year":"2015","journal-title":"Stem Cells"},{"key":"B116","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1073\/pnas.1107807108","article-title":"Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-\u03b2 and integrin\/focal adhesion kinase (FAK) signaling","volume":"108","author":"Schober","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/leu.2013.19","article-title":"Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients","volume":"27","author":"Mustjoki","year":"2013","journal-title":"Leukemia"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1007\/s10637-015-0282-y","article-title":"A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors","volume":"33","author":"Jones","year":"2015","journal-title":"Invest New Drugs"},{"key":"B119","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.18632\/oncotarget.2381","article-title":"FAK inhibition with small molecule inhibitor Y15 decreases viability, clonogenicity, and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics","volume":"5","author":"O\u2019Brien","year":"2014","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","first-page":"237ra68","DOI":"10.1126\/scitranslmed.3008639","article-title":"Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship","volume":"6","author":"Shapiro","year":"2014","journal-title":"Sci Transl Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1158\/0008-5472.CAN-14-1223","article-title":"PI3K\/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells","volume":"75","author":"Kolev","year":"2015","journal-title":"Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.18632\/oncotarget.762","article-title":"A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia","volume":"3","author":"Chiarini","year":"2012","journal-title":"Oncotarget"},{"key":"B123","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/0008-5472.CAN-11-1831","article-title":"ERK1\/2 regulation of CD44 modulates oral cancer aggressiveness","volume":"72","author":"Judd","year":"2012","journal-title":"Cancer Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1073\/pnas.1424171112","article-title":"Suppression of cancer relapse and metastasis by inhibiting cancer stemness","volume":"112","author":"Li","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/ijc.28690","article-title":"Emerging role of nanog in tumorigenesis and cancer stem cells","volume":"135","author":"Iv Santaliz-Ruiz","year":"2014","journal-title":"Int J Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B128","doi-asserted-by":"publisher","first-page":"10574","DOI":"10.1073\/pnas.1409844111","article-title":"Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells","volume":"111","author":"Janzer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br J Cancer"},{"key":"B130","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.18632\/oncotarget.2166","article-title":"Liposome encapsulated Disulfiram inhibits NF-\u03baB pathway and targets breast cancer stem cells in vitro and in vivo","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"B131","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.4161\/cc.9.22.14048","article-title":"Metformin against TGF\u03b2-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis","volume":"9","author":"Cuf\u00ed","year":"2010","journal-title":"Cell Cycle"},{"key":"B132","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","article-title":"Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal","volume":"20","author":"Li","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"B134","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1158\/1535-7163.MCT-13-0225-T","article-title":"Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancer","volume":"13","author":"Lee","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B135","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B136","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer","volume":"18","author":"Slomovitz","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"Yilmaz","year":"2006","journal-title":"Nature"},{"key":"B138","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ijc.28341","article-title":"Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K\/Akt\/\u03b2-catenin\/CBP pathway","volume":"134","author":"He","year":"2014","journal-title":"Int J Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"16158","DOI":"10.1073\/pnas.0702596104","article-title":"Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/1440-1681.12493","article-title":"PI3K\/Akt\/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells","volume":"42","author":"Chen","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1158\/0008-5472.CAN-13-1541","article-title":"CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist","volume":"74","author":"Sarvi","year":"2014","journal-title":"Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1158\/1078-0432.CCR-13-3389","article-title":"Dual mTORC1\/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival","volume":"20","author":"Luchman","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2013.10","article-title":"Development of PI3K inhibitors: lessons learned from early clinical trials","volume":"10","author":"Rodon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e875","DOI":"10.1038\/cddis.2013.407","article-title":"Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K\/Akt\/mTOR pathway in prostate cancer radioresistance","volume":"4","author":"Chang","year":"2013","journal-title":"Cell Death Dis"},{"key":"B145","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B146","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"B147","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1158\/0008-5472.CAN-13-1385","article-title":"Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer","volume":"73","author":"Balko","year":"2013","journal-title":"Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e50690","DOI":"10.1371\/journal.pone.0050690","article-title":"Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling","volume":"7","author":"Hepburn","year":"2012","journal-title":"PLoS One"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-10-2817","article-title":"Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations","volume":"71","author":"Fischer","year":"2011","journal-title":"Cancer Res"},{"key":"B150","doi-asserted-by":"publisher","first-page":"e46891","DOI":"10.1371\/journal.pone.0046891","article-title":"EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential","volume":"7","author":"Sette","year":"2012","journal-title":"PLoS One"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/carcin\/bgq120","article-title":"Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells","volume":"31","author":"Wang","year":"2010","journal-title":"Carcinogenesis"},{"key":"B152","doi-asserted-by":"publisher","first-page":"135","DOI":"10.18632\/oncotarget.240","article-title":"Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health","volume":"2","author":"Chappell","year":"2011","journal-title":"Oncotarget"},{"key":"B153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8140422","article-title":"Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin\u20136","volume":"264","author":"Zhong","year":"1994","journal-title":"Science"},{"key":"B154","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.131568898","article-title":"Stat3\u2013mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis","volume":"98","author":"Bowman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.7541555","article-title":"Enhanced DNA-binding activity of a Stat3\u2013related protein in cells transformed by the Src oncoprotein","volume":"269","author":"Yu","year":"1995","journal-title":"Science"},{"key":"B156","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B157","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1158\/0008-5472.CAN-10-4660","article-title":"STAT3 is necessary for proliferation and survival in colon cancer-initiating cells","volume":"71","author":"Lin","year":"2011","journal-title":"Cancer Res"},{"key":"B158","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1158\/0008-5472.CAN-14-2498","article-title":"IL6\/JAK1\/STAT3 signaling blockade in endometrial cancer affects the ALDHhi\/CD126+ stem-like component and reduces tumor burden","volume":"75","author":"van der Zee","year":"2015","journal-title":"Cancer Res"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/0008-5472.CAN-13-0594","article-title":"Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling","volume":"74","author":"Schroeder","year":"2014","journal-title":"Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-13-3292","article-title":"Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway","volume":"20","author":"Shao","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1158\/1078-0432.CCR-13-0621","article-title":"HAb18G\/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s","volume":"19","author":"Li","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3892\/ijo.2013.1765","article-title":"PI3K\/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line","volume":"42","author":"Moon","year":"2013","journal-title":"Int J Oncol"},{"issue":"3","key":"B163","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling nature\u2019s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)","volume":"79","author":"Baell","year":"2016","journal-title":"J Nat Prod"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.02.004","article-title":"Filtering promiscuous compounds in early drug discovery: is it a good idea?","author":"Senger","year":"2016","journal-title":"Drug Discov Today"},{"key":"B165","doi-asserted-by":"publisher","first-page":"E435","DOI":"10.1073\/pnas.1311121111","article-title":"Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK","volume":"111","author":"Liu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B166","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nm.2661","article-title":"Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia","volume":"18","author":"Schenk","year":"2012","journal-title":"Nat Med"},{"key":"B167","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1756-8722-7-28","article-title":"Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model","volume":"7","author":"Zhang","year":"2014","journal-title":"J Hematol Oncol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"B169","first-page":"747","article-title":"Radiotherapy targeting cancer stem cells: current views and future perspectives","volume":"33","author":"Ogawa","year":"2013","journal-title":"Anticancer Res"},{"key":"B170","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-012-0887-3","article-title":"Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma?","volume":"109","author":"Gupta","year":"2012","journal-title":"J Neurooncol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"B172","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1073\/pnas.1110431108","article-title":"Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Lu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B173","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cbi.2014.12.002","article-title":"Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling","volume":"228","author":"Lu","year":"2015","journal-title":"Chem Biol Interact"},{"key":"B174","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.toxlet.2013.07.022","article-title":"Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species","volume":"222","author":"Zhou","year":"2013","journal-title":"Toxicol Lett"},{"key":"B175","doi-asserted-by":"publisher","first-page":"e0141919","DOI":"10.1371\/journal.pone.0141919","article-title":"Salinomycin promotes anoikis and decreases the CD44+\/CD24- stem-like population via inhibition of STAT3 activation in MDA-MB-231 Cells","volume":"10","author":"An","year":"2015","journal-title":"PLoS One"},{"key":"B176","doi-asserted-by":"publisher","first-page":"950658","DOI":"10.1155\/2012\/950658","article-title":"Salinomycin as a drug for targeting human cancer stem cells","volume":"2012","author":"Naujokat","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0002-9343(90)90534-K","article-title":"Disulfiram treatment of alcoholism","volume":"88","author":"Wright","year":"1990","journal-title":"Am J Med"},{"key":"B178","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF01877380","article-title":"Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study","volume":"6","author":"Dufour","year":"1993","journal-title":"Biotherapy"},{"key":"B179","doi-asserted-by":"publisher","first-page":"40907","DOI":"10.18632\/oncotarget.5723","article-title":"Disulfiram inhibits TGF-\u03b2-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK\/NF-\u03baB\/Snail pathway","volume":"6","author":"Han","year":"2015","journal-title":"Oncotarget"},{"key":"B180","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.18632\/oncotarget.707","article-title":"High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells","volume":"3","author":"Hothi","year":"2012","journal-title":"Oncotarget"},{"key":"B181","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","article-title":"A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer","volume":"20","author":"Nechushtan","year":"2015","journal-title":"Oncologist"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e47357","DOI":"10.1371\/journal.pone.0047357","article-title":"Chloroquine or chloroquine-PI3K\/Akt pathway inhibitor combinations strongly promote gamma-irradiation-induced cell death in primary stem-like glioma cells","volume":"7","author":"Firat","year":"2012","journal-title":"PLoS One"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1158\/1535-7163.MCT-13-0948","article-title":"Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling","volume":"13","author":"Balic","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B184","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/156652309789753356","article-title":"Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas","volume":"9","author":"Jiang","year":"2009","journal-title":"Curr Gene Ther"},{"key":"B185","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/stem.1746","article-title":"Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1","volume":"32","author":"Choi","year":"2014","journal-title":"Stem Cells"},{"key":"B186","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"B187","doi-asserted-by":"publisher","first-page":"11499","DOI":"10.1158\/0008-5472.CAN-07-5312","article-title":"Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter","volume":"67","author":"Alonso","year":"2007","journal-title":"Cancer Res"},{"key":"B188","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1158\/0008-5472.CAN-11-1400","article-title":"Cancer stem cell vaccination confers significant antitumor immunity","volume":"72","author":"Ning","year":"2012","journal-title":"Cancer Res"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1158\/0008-5472.CAN-13-1942","article-title":"Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma","volume":"74","author":"Favaro","year":"2014","journal-title":"Cancer Res"},{"key":"B190","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1158\/0008-5472.CAN-15-1208","article-title":"Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer","volume":"76","author":"Lanzardo","year":"2016","journal-title":"Cancer Res"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00262-013-1453-3","article-title":"Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma","volume":"62","author":"Vik-Mo","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B192","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11060-013-1334-9","article-title":"Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells","volume":"116","author":"Xu","year":"2014","journal-title":"J Neurooncol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3324\/haematol.2010.031674","article-title":"Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies","volume":"96","author":"Rezvani","year":"2011","journal-title":"Haematologica"},{"key":"B194","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"B195","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s13346-012-0113-z","article-title":"Drug resistant breast cancer cell line displays cancer stem cell phenotype and responds sensitively to epigenetic drug SAHA","volume":"3","author":"Lu","year":"2013","journal-title":"Drug Deliv Transl Res"},{"key":"B196","doi-asserted-by":"publisher","first-page":"e24099","DOI":"10.1371\/journal.pone.0024099","article-title":"Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells","volume":"6","author":"Nalls","year":"2011","journal-title":"PLoS One"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472","article-title":"An epigenetic reprogramming strategy to re-sensitize radioresistant prostate cancer cells","author":"Peitzsch","year":"2016","journal-title":"Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbcan.2012.04.008","article-title":"The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness","volume":"1826","author":"Bao","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B199","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2011.09.007","article-title":"How to improve exposure of tumor cells to drugs \u2013 promoter drugs increase tumor uptake and penetration of effector drugs","volume":"64","author":"Marcucci","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.drudis.2012.06.004","article-title":"Improving drug penetration to curb tumor drug resistance","volume":"17","author":"Marcucci","year":"2012","journal-title":"Drug Discov Today"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.addr.2013.09.019","article-title":"Nanomedicine therapeutic approaches to overcome cancer drug resistance","volume":"65","author":"Markman","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"B202","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1359-6446(03)02988-X","article-title":"Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progresses","volume":"9","author":"Marcucci","year":"2004","journal-title":"Drug Discov Today"},{"key":"B203","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4161\/mabs.22775","article-title":"Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells","volume":"5","author":"Marcucci","year":"2013","journal-title":"MAbs"},{"key":"B204","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.biomaterials.2011.09.072","article-title":"The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"B205","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1073\/pnas.1304504110","article-title":"Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma","volume":"110","author":"Zhou","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"B207","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1158\/1078-0432.CCR-08-0291","article-title":"Sonic hedgehog promotes desmoplasia in pancreatic cancer","volume":"14","author":"Bailey","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B208","doi-asserted-by":"publisher","first-page":"415721","DOI":"10.1155\/2014\/415721","article-title":"Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients","volume":"2014","author":"Krawczyk","year":"2014","journal-title":"Biomed Res Int"},{"key":"B209","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1158\/0008-5472.CAN-13-0260","article-title":"HER2 and breast cancer stem cells: more than meets the eye","volume":"73","author":"Korkaya","year":"2013","journal-title":"Cancer Res"},{"key":"B210","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2013-08-355818","article-title":"Notch signaling: switching an oncogene to a tumor suppressor","volume":"123","author":"Lobry","year":"2014","journal-title":"Blood"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nm.3678","article-title":"A new tumor suppressor role for the Notch pathway in bladder cancer","volume":"20","author":"Rampias","year":"2014","journal-title":"Nat Med"},{"key":"B212","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF-\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1073\/pnas.1317731111","article-title":"Glycogen synthase kinase 3 inhibitors induce the canonical WNT\/\u03b2-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B214","doi-asserted-by":"publisher","first-page":"E2361","DOI":"10.1073\/pnas.1201232109","article-title":"STAT3 negatively regulates thyroid tumorigenesis","volume":"109","author":"Couto","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","article-title":"Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy","volume":"5","author":"Sotillo","year":"2015","journal-title":"Cancer Discov"},{"key":"B216","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.3390\/ijms15058335","article-title":"Apoptotic death of cancer stem cells for cancer therapy","volume":"15","author":"He","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B217","doi-asserted-by":"publisher","first-page":"12877","DOI":"10.18632\/oncotarget.2657","article-title":"Metformin and salinomycin as the best combination for the eradication of NSCLC monolayer cells and their alveospheres (cancer stem cells) irrespective of EGFR, KRAS, EML4\/ALK and LKB1 status","volume":"5","author":"Xiao","year":"2014","journal-title":"Oncotarget"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:58:42Z","timestamp":1498309122000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2016.00115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":217,"URL":"https:\/\/doi.org\/10.3389\/fonc.2016.00115","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}